Richard J. Armitage

11.5k total citations · 5 hit papers
75 papers, 9.3k citations indexed

About

Richard J. Armitage is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Richard J. Armitage has authored 75 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Immunology, 14 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in Richard J. Armitage's work include Immune Cell Function and Interaction (47 papers), T-cell and B-cell Immunology (41 papers) and Immunotherapy and Immune Responses (38 papers). Richard J. Armitage is often cited by papers focused on Immune Cell Function and Interaction (47 papers), T-cell and B-cell Immunology (41 papers) and Immunotherapy and Immune Responses (38 papers). Richard J. Armitage collaborates with scholars based in United States, Canada and United Kingdom. Richard J. Armitage's co-authors include William C. Fanslow, Melanie K. Spriggs, Brian M. Macduff, Mark R. Alderson, L Strockbine, Teresa W. Tough, Sally Painter, Kenneth H. Grabstein, Craig A. Smith and Zemin Yao and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Richard J. Armitage

75 papers receiving 8.9k citations

Hit Papers

Molecular and biological characterization of a murine lig... 1992 2026 2003 2014 1992 1995 1993 1993 1993 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard J. Armitage United States 45 7.1k 1.8k 1.6k 835 716 75 9.3k
William C. Fanslow United States 58 9.6k 1.4× 2.3k 1.3× 2.3k 1.4× 1.3k 1.5× 959 1.3× 108 13.1k
Iqbal S. Grewal United States 56 7.7k 1.1× 2.3k 1.3× 2.0k 1.2× 837 1.0× 808 1.1× 125 10.8k
Otto Majdic Austria 59 6.8k 1.0× 1.9k 1.1× 2.5k 1.5× 648 0.8× 663 0.9× 192 10.5k
M P Beckmann United States 33 3.8k 0.5× 1.7k 0.9× 1.9k 1.2× 583 0.7× 404 0.6× 44 6.9k
Thierry Defrance France 42 4.6k 0.7× 962 0.5× 1.3k 0.8× 585 0.7× 343 0.5× 85 6.7k
Sem Saeland France 40 6.8k 1.0× 1.2k 0.7× 1.4k 0.8× 632 0.8× 277 0.4× 74 8.7k
Hisaya Akiba Japan 53 8.3k 1.2× 3.4k 1.9× 2.0k 1.2× 712 0.9× 587 0.8× 126 10.8k
Peter J. L. Lane United Kingdom 46 7.4k 1.0× 1.2k 0.7× 1.3k 0.8× 543 0.7× 312 0.4× 106 9.0k
J A Ledbetter United States 52 9.4k 1.3× 2.0k 1.1× 3.2k 2.0× 703 0.8× 637 0.9× 99 12.7k
Kyoko Hayakawa United States 50 10.1k 1.4× 1.2k 0.7× 2.2k 1.3× 536 0.6× 475 0.7× 110 12.5k

Countries citing papers authored by Richard J. Armitage

Since Specialization
Citations

This map shows the geographic impact of Richard J. Armitage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Armitage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Armitage more than expected).

Fields of papers citing papers by Richard J. Armitage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Armitage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Armitage. The network helps show where Richard J. Armitage may publish in the future.

Co-authorship network of co-authors of Richard J. Armitage

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Armitage. A scholar is included among the top collaborators of Richard J. Armitage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Armitage. Richard J. Armitage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Wenbin, Richard J. Armitage, John R. Arrand, et al.. (2007). CD154 Tone Sets the Signaling Pathways and Transcriptome Generated in Model CD40-Pluricompetent L3055 Burkitt’s Lymphoma Cells. The Journal of Immunology. 179(5). 2705–2712. 14 indexed citations
2.
Kennedy, Mary K., Cynthia R. Willis, & Richard J. Armitage. (2006). Deciphering CD30 ligand biology and its role in humoral immunity. Immunology. 118(2). 143–152. 100 indexed citations
3.
Park, Chan-Sik, Sun-Ok Yoon, Richard J. Armitage, & Yong Sung Choi. (2004). Follicular Dendritic Cells Produce IL-15 That Enhances Germinal Center B Cell Proliferation in Membrane-Bound Form. The Journal of Immunology. 173(11). 6676–6683. 82 indexed citations
4.
6.
Armitage, Richard J.. (1994). Tumor necrosis factor receptor superfamily members and their ligands. Current Opinion in Immunology. 6(3). 407–413. 254 indexed citations
7.
Renshaw, Blair R., William C. Fanslow, Richard J. Armitage, et al.. (1994). Humoral immune responses in CD40 ligand-deficient mice.. The Journal of Experimental Medicine. 180(5). 1889–1900. 460 indexed citations
8.
Spriggs, Melanie K., William C. Fanslow, Richard J. Armitage, & John W. Belmont. (1993). The biology of the human ligand for CD40. Journal of Clinical Immunology. 13(6). 373–380. 30 indexed citations
9.
Jardim, Armando, E M Carvalho, P R Sleath, et al.. (1993). Mapping human T cell epitopes in Leishmania gp63: identification of cross-reactive and species-specific epitopes. The Journal of Immunology. 150(10). 4713–4713. 31 indexed citations
10.
Armitage, Richard J., et al.. (1993). Antigen-reactive gamma delta T cells in human leishmaniasis.. The Journal of Immunology. 151(7). 3712–3718. 52 indexed citations
11.
Goodwin, Raymond G., Wenie S. Din, Terri Davis‐Smith, et al.. (1993). Molecular cloning of a ligand for the inducible T cell gene 4‐1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. European Journal of Immunology. 23(10). 2631–2641. 280 indexed citations
12.
Armitage, Richard J., Charles R. Maliszewski, Mark R. Alderson, et al.. (1993). CD40L: a multi-functional ligand. Seminars in Immunology. 5(6). 404–412. 70 indexed citations
13.
Fanslow, William C., Dirk Anderson, Kenneth H. Grabstein, et al.. (1992). Soluble forms of CD40 inhibit biologic responses of human B cells. The Journal of Immunology. 149(2). 655–660. 138 indexed citations
14.
Armitage, Richard J., William C. Fanslow, L Strockbine, et al.. (1992). Molecular and biological characterization of a murine ligand for CD40. Nature. 357(6373). 80–82. 875 indexed citations breakdown →
15.
Armitage, Richard J., Timothy A. Sato, Brian M. Macduff, et al.. (1992). Identification of a source of biologically active CD40 ligand. European Journal of Immunology. 22(8). 2071–2076. 68 indexed citations
16.
Spriggs, Melanie K., Richard J. Armitage, L Strockbine, et al.. (1992). Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion.. The Journal of Experimental Medicine. 176(6). 1543–1550. 338 indexed citations
17.
Ziegler, Steven F., et al.. (1991). Induction of macrophage inflammatory protein-1 beta gene expression in human monocytes by lipopolysaccharide and IL-7. The Journal of Immunology. 147(7). 2234–2239. 65 indexed citations
18.
Fanslow, William C., K N Clifford, Tim VandenBos, et al.. (1990). A soluble form of the interleukin 4 receptor in biological fluids. Cytokine. 2(6). 398–401. 35 indexed citations
19.
Armitage, Richard J., et al.. (1986). Certain myeloid cells possess receptors for interleukin‐2. British Journal of Haematology. 64(4). 799–807. 47 indexed citations
20.
Moss, Fiona, et al.. (1985). Bone marrow macrophages and megakaryocytes express common acute lymphoblastic leukaemia antigen. Leukemia Research. 9(9). 1155–1159. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026